Mario Gabelli Buys 2, Sells 3 in 2nd Quarter

Mario Gabelli recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

Mario J. Gabelli is the Chairman and Chief Executive Officer of GAMCO Investors Inc., the firm he founded in 1977. A 1965 summa cum laude graduate of Fordham University's College of Business Administration, he also holds an M.B.A. from Columbia University Graduate School of Business and honorary doctorates from Fordham University and Roger Williams University.
Gabelli serves on the Boards of Boston College, Roger Williams University, Columbia University Graduate School of Business, the American-Italian Cancer Foundation, the Foundation for Italian Art & Culture and is a Trustee of the Winston Churchill Foundation of the United States and of the E.L. Wiegand Foundation. He was Morningstar's Portfolio Manager of the Year in 1997. He was named Money Manager of the Year by Institutional Investor for 2011 and is a member of Barron's All Star Century Team.

As of the latest 13F report, the guru’s equity portfolio contained 883 stocks valued at a total of $9.12Bil. The top holdings were HRI(1.89%), MLI(1.78%), and GATX(1.66%).

According to GuruFocus data, these were Mario Gabelli (Trades, Portfolio)’s top five trades of the quarter.

GCP Applied Technologies Inc


Mario Gabelli (Trades, Portfolio) reduced their investment in NYSE:GCP by 2,498,748 shares. The trade had a 0.71% impact on the equity portfolio. During the quarter, the stock traded for an average price of $31.17.

On 08/12/2022, GCP Applied Technologies Inc traded for a price of $31.55 per share and a market cap of $2.34Bil. The stock has returned 32.51% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, GCP Applied Technologies Inc has a price-earnings ratio of 225.35, a price-book ratio of 3.61, a price-earnings-to-growth (PEG) ratio of 54.77, a EV-to-Ebitda ratio of 25.25 and a price-sales ratio of 2.32.

The price-to-GF Value ratio is 1.29, earning the stock a GF Value rank of 3.

Ferro Corp


The guru sold out of their 2,717,069-share investment in NYSE:FOE. Previously, the stock had a 0.53% weight in the equity portfolio. Shares traded for an average price of $21.75 during the quarter.

On 08/12/2022, Ferro Corp traded for a price of $22.01 per share and a market cap of $1.84Bil. The stock has returned 27.74% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 6 out of 10.

In terms of valuation, Ferro Corp has a price-earnings ratio of 12.44, a price-book ratio of 3.42, a price-earnings-to-growth (PEG) ratio of 17.26, a EV-to-Ebitda ratio of 11.35 and a price-sales ratio of 1.63.

The price-to-GF Value ratio is 1.16, earning the stock a GF Value rank of 3.

IntriCon Corp


The guru sold out of their 791,951-share investment in NAS:IIN. Previously, the stock had a 0.17% weight in the equity portfolio. Shares traded for an average price of $24.01 during the quarter.

On 08/12/2022, IntriCon Corp traded for a price of $24.24 per share and a market cap of $225.49Mil. The stock has returned -2.69% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 5 out of 10.

In terms of valuation, IntriCon Corp has a price-book ratio of 2.40, a EV-to-Ebitda ratio of 36.37 and a price-sales ratio of 1.78.

The price-to-GF Value ratio is 1.20, earning the stock a GF Value rank of 3.

Alleghany Corp


During the quarter, Mario Gabelli (Trades, Portfolio) bought 16,668 shares of NYSE:Y for a total holding of 23,578. The trade had a 0.16% impact on the equity portfolio. During the quarter, the stock traded for an average price of $836.63.

On 08/12/2022, Alleghany Corp traded for a price of $838.5 per share and a market cap of $11.28Bil. The stock has returned 22.67% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, Alleghany Corp has a price-earnings ratio of 33.07, a price-book ratio of 1.42, a price-earnings-to-growth (PEG) ratio of 1.48, a EV-to-Ebitda ratio of 13.49 and a price-sales ratio of 0.98.

The price-to-GF Value ratio is 0.99, earning the stock a GF Value rank of 7.

CVS Health Corp


During the quarter, Mario Gabelli (Trades, Portfolio) bought 112,305 shares of NYSE:CVS for a total holding of 360,626. The trade had a 0.12% impact on the equity portfolio. During the quarter, the stock traded for an average price of $97.65.

On 08/12/2022, CVS Health Corp traded for a price of $106.39 per share and a market cap of $139.67Bil. The stock has returned 27.48% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, CVS Health Corp has a price-earnings ratio of 17.31, a price-book ratio of 1.86, a price-earnings-to-growth (PEG) ratio of 3.33, a EV-to-Ebitda ratio of 11.39 and a price-sales ratio of 0.46.

The price-to-GF Value ratio is 1.22, earning the stock a GF Value rank of 3.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.